1. Executive Summary (Confidence: High)

HBM Healthcare Investments AG (SIX: HBMN) is a major Swiss investment firm with a market capitalization of approximately CHF 1.56 billion and net assets exceeding CHF 1. billion.^[47] Founded in 2001 by former Roche CFO Henri B. Meier, the company builds high-value portfolios across the human medicine, biotechnology, medical technology, and diagnostics sectors.^[47] HBM distinguishes itself through an "active investment approach," often taking board seats in private companies to steer them toward successful trade sales or initial public offerings (IPOs).^[47] With a globally diversified footprint spanning North America, Europe, and Asia, HBM provides its shareholders with exposure to a curated selection of over 45 high-growth healthcare companies, delivering consistent returns through dividends and capital gains.^[47]